DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20220671
Published: 2022-02-28

Prevalence of E. coli as a causative agent of urinary tract infections and its drug susceptibility patterns among pregnant mothers seeking medicare at Kisii teaching and referral hospital, Kenya

Sosmus M. Simba, Eric O. Omwenga, Stanslaus K. Musyoki

Abstract


Background: E-coli, a gram-negative entero-bacteria has been associated with urinary tract infections (UTIs) and antimicrobial resistances in human and animals. This study aimed at establishing the prevalence of E. coli among other bacteria causing UTIs in pregnant women seeking Medicare at Kisii teaching and referral hospital (KTRH), Kenya and to establish the drug susceptibility patterns of the isolated E. coli. Setting-The project was done at Kisii teaching and referral hospital, Kenya.

Methods: This hospital based experimental and cross-sectional study conducted in 3 months between March and June 2020 involved 119 pregnant women whose urine samples were cultured on Cysteine Leucine Electrolyte deficiency media (CLED) at 370C overnight and sub-cultured on Mueller Hinton media. Bacterial identification was done by Gram stain and biochemical characterization using indole, methyl-red, Voges-Proskaur and citrate tests while susceptibility tests were conducted by Kirby Bauer disc diffusion technique.

Results: Out of the 119 urine samples, E. coli 28 (23.5%) was the second most prevalent after S. aureus 40 (33.6%). Others included S. epidermidis 27 (22.7%), and Proteus spp. 9 (7.6%). All E. coli isolates, 28 (100%) demonstrated resistance to sulfamethoxazole followed by amoxyclave 24 (85.75%), and ceftriaxone 20 (71.42%). They were least resistant to gentamycin 4 (14. 28%) and ofloxacin 6 (21.42%).

Conclusions: E. coli which largely exists as a commensal can cause UTIs and could be possessing antimicrobial resistant genes responsible for treatment failure. This             demands for new effective therapeutic alternatives and more research on bacterial drug resistant.


Keywords


E. coli, Drug susceptibility, Resistance, Pregnant women, Kisii Kenya

Full Text:

PDF

References


Olin SJ, Bartges JW. Urinary Tract Infections. Treatment/Comparative Therapeutics. Vet Clin North Am Small Anim Pract. 2015;45(4):721-46.

Ebidor UL, Tolulope A, Deborah O. Urinary tract infection amongst pregnant women in Amassoma, Southern Nigeria. Afr J Microbiol Res. 2015;9(6):355-9.

Jhang JF, KuoTzu HC. Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention. Chi Med J. 2017;29(3):131-7.

Nj M, Mogaka G, Nyambane L, Eilu E. Prevalence and susceptibility pattern of bacterial Urinary Tract Infections among pregnant HIV positive women in Gucha sub county, Kenya 1. AIDS SBPJ Special Bacterial Pathogens J. 2015;1(1):10-15.

Sharifinia M, Karimi A, Rafiee S, Anvaripour N. Microbial sensitivity pattern in urinary tract infections in children: a single centre experience of 1177 urine cultures. Jap J Infect Dis. 2006;59:380-82.

Chukwudozie Onuoha S, Fatokun K. Prevalence and antimicrobial susceptibility pattern of Urinary Tract Infection (UTI) among pregnant women in Afikpo, Ebonyi State, Nigeria. Am J Life Sci. 2014:2(2):46-52.

Johnson TJ, Nolan LK. Pathogenomics of the Virulence Plasmids of Escherichia coli. Microbiol Mol Biol Reviews. 2009;73(4):750-74.

Nji E, Kazibwe J, Hambridge T. High prevalence of antibiotic resistance in commensal Escherichia coli from healthy human sources in community settings. Sci Rep. 2021;11:3372.

Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T. World Health Organization Report: Current Crisis of Antibiotic Resistance. Bio Nano Sci. 2019;9:778-88.

World Health Organization. 2019 Antibacterial Agents in Clinical Development: Analysis of the Antibacterial Clinical Development Pipeline; WHO: Geneva, Switzerland, https://www.who.int/medicines/areas/rational_use/antibacterial_agents_clinical_development/en/. Accessed on 24 April 2020.

Campo-Urbina M. Caracterización y perfil de susceptibilidad de uropatógenos asociados a la presencia de bacteriuria asintomática en gestantes del departamento del Atlántico, Colombia, 2014-2015. Estudio de corte transversal. Rev Colomb Obstet Ginecol. 2017;68:62-71.

Córdova E, Lespada MI, Cecchini D. Prevalencia de gérmenes multirresistentes enh ninfecciones del tracto urinario de la comunidad y asociadas a los cuidados de la salud. Actual SIDA Infectol. 2014;22:33-8.

Fatima T, Rafiq S, Iqbal A. Prevalence and Antibiogram of MDR E. coli Strains Isolated from UTI Patients-1-Year Retrospective Study at Nishtar Medical Hospital, Multan. SN Compr Clin Med. 2020;2:423-31.

Mhondoro M, Ndlovu N, Bangure D. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis. BMC Infect Dis. 2019;19:746.

Odongo I, Ssemambo R, Kungu JM. Prevalence of Escherichia Coli and Its Antimicrobial Susceptibility Profiles among Patients with UTI at Mulago Hospital, Kampala, Uganda. Interdiscip Perspect Infect Dis. 2020;2020:8042540.

Muloi D, Melissa J, Ward, James M. Epidemiology of antimicrobial-resistant Escherichia coli carriage in sympatric humans and livestock in a rapidly urbanizing city. Int J Antimicrob Agents. 2019;54(5):531-7.

Charan J, Biswas T. How to Calculate Sample Size for Different Study Designs in Medical Research. Indian J Psychol Med. 2013;35(2):121-6.

Habak PJ, Griggs, Jr RP. Urinary Tract Infection In Pregnancy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.

Johnson B, Stephen BM, Joseph N, Asiphas O, Musa K, Taseera K. Prevalence and bacteriology of culture-positive urinary tract infection among pregnant women with suspected urinary tract infection at Mbarara regional referral hospital, South-Western Uganda. BMC Pregnancy Childbirth. 2021;21(1):159.

Ahmed MA, Shukla GA and Bajaj HK. Incidence of Urinary Tract Infections and determination of their susceptibility to antibiotics among Pregnant Women Department of medical Laboratory Technology, Sam Higginbottom. 2017.

Mnyambwa NP, Mahende C, Wilfred A, Sandi E, Mgina N, Lubinza C et al. Antibiotic Susceptibility Patterns orbgf Bacterial Isolates from Routine Clinical Specimens from Referral Hospitals in Tanzania: A Prospective Hospital-Based Observational Study. Infect Drug Resist. 2021;14:869-78.

Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69:4572-9.

Laily F, Lutan D, Amelia S, Tala MRZ, Nasution TA. Associated risk factors for urinary tract infection among pregnant women at Puskesmas Kenangan, Deli Serdang district. Conf Ser Earth Environ Sci. 2018;125:012035.

Wabe, Awol Y. Prevalence of Asymptomatic Bacteriuria, Associated Factors and Antimicrobial Susceptibility Profile of Bacteria Among Pregnant Women Attending Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. Therapeutics Clin Risk Manag. 2020;16:923-32.

Ayoyi AO, Kikuvi G, Bii C, Kariuki S. Prevalence, aetiology and antibiotic sensitivity profile of asymptomatic bacteriuria isolates from pregnant women in selected antenatal clinic from Nairobi, Kenya. Pan Afr Med J. 2017;26:30-41.

WHO. Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug Resistant Bacterial Infections, Including Tuberculosis, 2017. Available at: https://apps.who.int/iris/handle/10665/. Accessed on 01 November 2021.

Hu L-F, Chen G-S, Kong Q-X, Gao L-P, Chen X, Ye Y et al. Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China. PLoS ONE. 2016;11(6):e0157693.

Klingeberg A, Noll I, Willrich N, Feig M, Emrich D, Zill E et al. Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection. Dtsch Arztebl Int. 2018;115(29-30):494-500.

Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob. 2018;17:34.

IA Critchley, N Cotroneo, MJ Pucci, R Mendes. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PloS one. 2019.

Ndung’u C, Muigai AWT, Kariuki S. Prevalence and Antibiotic Resistance Patterns of Escherichia Coli Among Hospitalised Patients At Thika District Hospital East African. Med J. 2014;91(6)2014.

Nyamache AK. Isolation and antimicrobial susceptibility testing of Escherichia coli causing urinary tract infections. J Applied Biosci. 2020;22(24):1320-25.

WHO: Antimicrobial Resistance: Global Report on surveillance. Available at: http://www.appswhoint/iris/bitstream/10665/188783/1/9789241549400_engpdf?ua=1 2015. Accessed on 2021 Feb 17.

Kariuki S, Okoro C, Kiiru J, Njoroge S, Omuse G, Langridge G et al. Ceftriaxone-resistant Salmonella enterica serotype typhimurium sequence type 313 from Kenyan patients is associated with the blaCTX-M-15 gene on a novel IncHI2 plasmid. Antimicrobial agents chemotherapy. 2015;59(6):3133-9.

Wolff O, Maclennan C. Evidence behind the WHO guidelines: hospital care for children: what is the appropriate empiric antibiotic therapy in uncomplicated urinary tract infections in children in developing countries? J Trop Pediatr. 2007;53:150-2.

Bui T, Preuss CV. Cephalosporins. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK551517/. Accessed on 2021 Feb 17.

Alanazi MQ, Alqahtani FY, Aleanizy FS. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Ann Clin Microbiol Antimicrob. 2018;17(1):3.

Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res. 2014;139(6):945-8.

Chua KYL, Stewardson AJ. Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia. Antimicrob Resist Infect Control. 2019;8:36.

Gunduz S, Uludağ Altun H. Antibiotic resistance patterns of urinary tract pathogens in Turkish children. Glob health res policy. 2018;3:10.

McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994;33(A):23-30.

Daoud N, Hamdoun M, Hannachi H, Gharsallah C, Mallekh W, Bahri O. Antimicrobial Susceptibility Patterns of Escherichia coli among Tunisian Outpatients with Community-Acquired Urinary Tract Infection (2012-2018). Curr Urol. 2020;14(4):200-5.

Correia S, Poeta P. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66:551-9.

Dinah Moraa Dr. Scholastica Mathenge, Dr. Arodi Washington,Torome Tom, Oliver Mbuthia,Martin Kinyu Antibiotic Susceptibility Pattern among Male Patients with Urinary Tract Infection in Special Treatment Centre,Nairobi County, Kenya.

Kotra LP, Haddad J, Mobashery S. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother. 2000;44(12):3249-56.

Vincent Mogaka Mageto V. Uropathogens antibiotic resistance patterns among type 2 diabetic patients in Kisii Teaching and Referral Hospital, Kenya. Pan African Medical J. 2018;30:286.

Wise R, Andrews JM, Bedford KA. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrob Agents Chemother. 1978;13(3):389-93.

Kutalek R, Wewalka G, Gundacker C, Auer H, Wilson J, Haluza D et al. Geophagy and potential health implications: geohelminths, microbes and heavy metals. Transactions Royal Society Trop Med Hygiene. 2010;104(12):787-95.

Zur Wiesch PA, Kouyos R, Engelstädter J, Regoes RR, Bonheoffer S. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect Dis. 011;11(3):236-47.